These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Interleukin-20 differentially regulates bone mesenchymal stem cell activities in RANKL-induced osteoclastogenesis through the OPG/RANKL/RANK axis and the NF-κB, MAPK and AKT signalling pathways. Meng B; Wu D; Cheng Y; Huang P; Liu Y; Gan L; Liu C; Cao Y Scand J Immunol; 2020 May; 91(5):e12874. PubMed ID: 32090353 [TBL] [Abstract][Full Text] [Related]
24. (5R)-5-Hydroxytriptolide (LLDT-8) inhibits osteoclastogenesis via RANKL/RANK/OPG signaling pathway. Shen Y; Jiang T; Wang R; He S; Guo M; Zuo J; He D BMC Complement Altern Med; 2015 Mar; 15():77. PubMed ID: 25887296 [TBL] [Abstract][Full Text] [Related]
25. Microbe sampling by mucosal dendritic cells is a discrete, MyD88-independent step in DeltainvG S. Typhimurium colitis. Hapfelmeier S; Müller AJ; Stecher B; Kaiser P; Barthel M; Endt K; Eberhard M; Robbiani R; Jacobi CA; Heikenwalder M; Kirschning C; Jung S; Stallmach T; Kremer M; Hardt WD J Exp Med; 2008 Feb; 205(2):437-50. PubMed ID: 18268033 [TBL] [Abstract][Full Text] [Related]
26. The Salmonella pathogenicity island (SPI)-2 and SPI-1 type III secretion systems allow Salmonella serovar typhimurium to trigger colitis via MyD88-dependent and MyD88-independent mechanisms. Hapfelmeier S; Stecher B; Barthel M; Kremer M; Müller AJ; Heikenwalder M; Stallmach T; Hensel M; Pfeffer K; Akira S; Hardt WD J Immunol; 2005 Feb; 174(3):1675-85. PubMed ID: 15661931 [TBL] [Abstract][Full Text] [Related]
27. Genetic deletion of muscle RANK or selective inhibition of RANKL is not as effective as full-length OPG-fc in mitigating muscular dystrophy. Dufresne SS; Boulanger-Piette A; Bossé S; Argaw A; Hamoudi D; Marcadet L; Gamu D; Fajardo VA; Yagita H; Penninger JM; Russell Tupling A; Frenette J Acta Neuropathol Commun; 2018 Apr; 6(1):31. PubMed ID: 29699580 [TBL] [Abstract][Full Text] [Related]
28. Expression of the RANK/RANKL/OPG system in the human intervertebral disc: implication for the pathogenesis of intervertebral disc degeneration. Sano T; Akeda K; Yamada J; Takegami N; Sudo T; Sudo A BMC Musculoskelet Disord; 2019 May; 20(1):225. PubMed ID: 31101043 [TBL] [Abstract][Full Text] [Related]
30. RANK/RANKL/OPG system in the intervertebral disc. Takegami N; Akeda K; Yamada J; Sano T; Murata K; Huang J; Masuda K; Sudo A Arthritis Res Ther; 2017 Jun; 19(1):121. PubMed ID: 28576140 [TBL] [Abstract][Full Text] [Related]
31. RANKL/RANK/OPG system beyond bone remodeling: involvement in breast cancer and clinical perspectives. Infante M; Fabi A; Cognetti F; Gorini S; Caprio M; Fabbri A J Exp Clin Cancer Res; 2019 Jan; 38(1):12. PubMed ID: 30621730 [TBL] [Abstract][Full Text] [Related]
32. Expression profile of receptor activator of nuclear-κB (RANK), RANK ligand (RANKL) and osteoprotegerin (OPG) in breast cancer. Owen S; Ye L; Sanders AJ; Mason MD; Jiang WG Anticancer Res; 2013 Jan; 33(1):199-206. PubMed ID: 23267146 [TBL] [Abstract][Full Text] [Related]
33. Limitation of immune tolerance-inducing thymic epithelial cell development by Spi-B-mediated negative feedback regulation. Akiyama N; Shinzawa M; Miyauchi M; Yanai H; Tateishi R; Shimo Y; Ohshima D; Matsuo K; Sasaki I; Hoshino K; Wu G; Yagi S; Inoue J; Kaisho T; Akiyama T J Exp Med; 2014 Nov; 211(12):2425-38. PubMed ID: 25385757 [TBL] [Abstract][Full Text] [Related]
34. Lactation induces increases in the RANK/RANKL/OPG system in maxillary bone. Macari S; Sharma LA; Wyatt A; da Silva JM; Dias GJ; Silva TA; Szawka RE; Grattan DR Bone; 2018 May; 110():160-169. PubMed ID: 29382610 [TBL] [Abstract][Full Text] [Related]
35. Lyn deficiency leads to increased microbiota-dependent intestinal inflammation and susceptibility to enteric pathogens. Roberts ME; Bishop JL; Fan X; Beer JL; Kum WW; Krebs DL; Huang M; Gill N; Priatel JJ; Finlay BB; Harder KW J Immunol; 2014 Nov; 193(10):5249-63. PubMed ID: 25339668 [TBL] [Abstract][Full Text] [Related]
36. Pioglitazone affects the OPG/RANKL/RANK system and increase osteoclastogenesis. Xu F; Dong Y; Huang X; Chen P; Guo F; Chen A; Huang S Mol Med Rep; 2016 Sep; 14(3):2289-96. PubMed ID: 27430581 [TBL] [Abstract][Full Text] [Related]
37. Regulation of receptor activator of nuclear factor-kappa B ligand and osteoprotegerin mRNA expression by parathyroid hormone is predominantly mediated by the protein kinase a pathway in murine bone marrow cultures. Lee SK; Lorenzo JA Bone; 2002 Jul; 31(1):252-9. PubMed ID: 12110442 [TBL] [Abstract][Full Text] [Related]
38. Antiresorptive activity of osteoprotegerin requires an intact heparan sulfate-binding site. Li M; Xu D Proc Natl Acad Sci U S A; 2020 Jul; 117(29):17187-17194. PubMed ID: 32636266 [TBL] [Abstract][Full Text] [Related]
39. The inhibition of RANKL/RANK signaling by osteoprotegerin suppresses bone invasion by oral squamous cell carcinoma cells. Shin M; Matsuo K; Tada T; Fukushima H; Furuta H; Ozeki S; Kadowaki T; Yamamoto K; Okamoto M; Jimi E Carcinogenesis; 2011 Nov; 32(11):1634-40. PubMed ID: 21890459 [TBL] [Abstract][Full Text] [Related]
40. Effect of technetium-99 conjugated with methylene diphosphonate ( Shen S; Wang W; Yang C; Xu B; Zeng L; Qian Y J Oral Pathol Med; 2019 Feb; 48(2):129-135. PubMed ID: 30421571 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]